Valeant Pharma Securities Fraud Case Settled for $1.2 Billion

A securities case filed against Valeant Pharmaceuticals International, Inc. (now Bausch Health Companies, Inc.) on behalf of both shareholders and bondholders has settled for $1.2 billion. Monument’s Cynthia Jones served as plaintiffs’ expert for holders of the eleven Senior Notes that will participate in the settlement, with total par value of $17.8 billion.

Read More